AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Nu Skin Enterprises, Inc.

$4.74 -$4.95 (-51.08%)
NYSE · 15 Sep 2026 20:00 UTC
Previous Close
$4.87
Day Range
$4.68$4.82
Year Range
$4.49$14.62
Market Cap
230.13M
AVG Volume
674.28K
Trailing/Forward PE
-1.06/4.09
PEG ratio
-0.03
Dividend Yield
5.06%
Next Earnings Date
2026-11-05
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
01B2B3B2016201720182019202020212022202320242025
NUS Revenue (USD) by year
PeriodRevenue (USD)
20251.49B
20241.73B
20231.97B
20222.23B
20212.7B
20202.58B
20192.42B
20182.68B
20172.28B
20162.21B
Net Income (USD)
-200M-100M0100M200M2016201720182019202020212022202320242025
NUS Net Income (USD) by year
PeriodNet Income (USD)
2025160.2M
2024-146.59M
20238.6M
2022104.78M
2021147.27M
2020191.35M
2019173.55M
2018121.89M
2017129.44M
2016143.09M
Operating Income (USD)
-200M0200M400M2016201720182019202020212022202320242025
NUS Operating Income (USD) by year
PeriodOperating Income (USD)
202565.76M
2024-151.59M
202348.27M
2022110.85M
2021233.99M
2020257.56M
2019267.43M
2018240.86M
2017274.48M
2016231.1M
EBITDA (USD)
-200M0200M400M600M2016201720182019202020212022202320242025
NUS EBITDA (USD) by year
PeriodEBITDA (USD)
2025262.41M
2024-78.83M
2023106.83M
2022221.75M
2021360.95M
2020331.56M
2019341.23M
2018401.75M
2017346.05M
2016303.5M
Cash Flows (USD)
0100M200M300M400M2016201720182019202020212022202320242025
NUS Cash Flows (USD) by year
PeriodCash Flows (USD)
202546.01M
202470.16M
202360.15M
202249.01M
202172.97M
2020315.32M
2019111.86M
2018132.37M
2017242.4M
2016225.04M
EPS (USD)
-4-20242016201720182019202020212022202320242025
NUS EPS (USD) by year
PeriodEPS (USD)
20253.2
2024-2.95
20230.18
20222.07
20212.85
20203.68
20193.11
20182.16
20172.37
20162.52
Expenses (USD)
0500M1B1.5B2BR&DSG&ACapex2016201720182019202020212022202320242025
NUS Expenses (USD) by year
PeriodExpenses (USD)
2025985.6M
20241.19B
20231.37B
20221.49B
20211.8B
20201.73B
20191.64B
20181.83B
20171.58B
20161.55B
Cash & Debt (USD)
0200M400M600MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
NUS Cash & Debt (USD) by year
PeriodCash & Debt (USD)
2025239.84M
2024197.99M
2023267.82M
2022278.51M
2021354.81M
2020423.9M
2019344.04M
2018398.26M
2017438.25M
2016368.13M
Debt ratios
00.20.40.620182019202020212022202320242025
NUS Debt ratios by year
PeriodDebt ratios
20250.24
20240.46
20230.33
20220.19
20210.1
20200.05
20190.12
20180.02
Margins
0%20%40%60%80%2016201720182019202020212022202320242025
NUS Margins by year
PeriodMargins
202569.45%
202468.23%
202368.93%
202271.65%
202174.95%
202074.51%
201975.98%
201876.33%
201777.97%
201677.33%
Return on Capital
-40%-20%0%20%40%2016201720182019202020212022202320242025
NUS Return on Capital by year
PeriodReturn on Capital
202519.9%
2024-22.5%
20231.05%
202211.68%
202116.13%
202021.4%
201919.83%
201815.59%
201718.37%
201621.55%
Shares Outstanding
020M40M60M2016201720182019202020212022202320242025
NUS Shares Outstanding by year
PeriodShares Outstanding
202548.58M
202449.71M
202349.41M
202249.45M
202149.86M
202050.96M
201955.55M
201855.45M
201752.72M
201653.77M
Dividends (USD)
00.511.522017201820192020202120222023202420252026
NUS Dividends (USD) by year
PeriodDividends (USD)
20260.18
20250.24
20240.24
20231.56
20221.54
20211.52
20201.5
20191.48
20181.46
20171.44
Employee Count
02K4K6K2016201720182019202020212022202320242025
NUS Employee Count by year
PeriodEmployee Count
20252.8K
20243.1K
20233.7K
20223.8K
20214.6K
20205K
20194.9K
20184.9K
20174.7K
20164.65K
Book Value Per Share (USD)
051015202016201720182019202020212022202320242025
NUS Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
202516.58
202413.1
202316.64
202218.14
202118.31
202017.55
201915.76
201814.1
201713.36
201612.35
Total Assets (USD)
0500M1B1.5B2B2016201720182019202020212022202320242025
NUS Total Assets (USD) by year
PeriodTotal Assets (USD)
20251.41B
20241.47B
20231.81B
20221.82B
20211.91B
20201.96B
20191.77B
20181.69B
20171.59B
20161.47B
PE Ratio
020406080med 5.96Aug 23Dec 23Mar 24Sep 25Jan 26Apr 26Aug 26
NUS PE Ratio by year
PeriodPE Ratio
Aug 264.85
Jul 264.59
Jul 264.49
Jul 264.63
Jul 264.62
Jul 264.43
Jun 264.67
Jun 264.44
Jun 264.84
Jun 264.75
May 265.12
May 265.24
May 265.41
May 266.33
May 262.18
Apr 262.29
Apr 262.4
Apr 262.28
Apr 262.25
Mar 262.16
Mar 262.16
Mar 262.17
Mar 262.31
Feb 262.57
Feb 262.64
Feb 262.54
Feb 264.87
Jan 264.78
Jan 264.98
Jan 265.2
Jan 264.66
Jan 264.37
Dec 254.43
Dec 254.63
Dec 254.78
Dec 254.5
Nov 254.46
Nov 254.52
Nov 254.34
Nov 254.11
Oct 255.26
Oct 255.4
Oct 255.24
Oct 255.05
Oct 255.58
Sep 256
Sep 255.93
Sep 255.9
Sep 255.63
Aug 255.97
Aug 255.95
Aug 255.67
Aug 254.38
May 2471.34
Apr 2470.77
Apr 2474.79
Apr 2469.27
Apr 2471.98
Mar 2479.51
Mar 2470.71
Mar 2476.17
Mar 2473.24
Mar 2472.66
Feb 2472.32
Feb 2478.7
Feb 2414.99
Feb 2415.47
Jan 2415.98
Jan 2414.81
Jan 2415.44
Jan 2415.87
Dec 2316.54
Dec 2316.48
Dec 2316.48
Dec 2315.11
Dec 2314.96
Nov 2314.71
Nov 2315.33
Nov 2314.07
Nov 2315.33
Oct 2313.16
Oct 2313.9
Oct 2313.07
Oct 2313.81
Sep 2315.11
Sep 2316.58
Sep 2317.1
Sep 2316.53
Sep 2317.09
Aug 2316.93
Aug 2317.34
Aug 2317.94
Aug 2318.69
Jul 2319.18
Jul 2318.36
Jul 2318.86
Jul 2319.67
Jun 2321.28
Jun 2320.59
Jun 2321.49
Free Cash Flow Yield
0%10%20%30%40%med 14.87%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NUS Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 264.56%
Sep 264.57%
Sep 264.58%
Aug 264.57%
Aug 264.68%
Aug 264.62%
Aug 2615.71%
Jul 2616.62%
Jul 2616.98%
Jul 2616.46%
Jul 2616.49%
Jul 2617.21%
Jun 2616.33%
Jun 2617.18%
Jun 2615.77%
Jun 2616.06%
May 2614.9%
May 2614.54%
May 2614.09%
May 2612.05%
May 2613.17%
Apr 2612.56%
Apr 2611.99%
Apr 2612.59%
Apr 2612.78%
Mar 2613.28%
Mar 2613.3%
Mar 2613.21%
Mar 2612.41%
Feb 2611.17%
Feb 2610.87%
Feb 2611.33%
Feb 269.99%
Jan 2610.18%
Jan 269.76%
Jan 269.36%
Jan 2610.46%
Jan 2611.15%
Dec 2510.98%
Dec 2510.52%
Dec 2510.18%
Dec 2510.82%
Nov 2510.92%
Nov 2510.78%
Nov 2511.23%
Nov 2511.84%
Oct 2511.06%
Oct 2510.76%
Oct 2511.09%
Oct 2511.52%
Oct 2510.43%
Sep 259.69%
Sep 259.81%
Sep 259.85%
Sep 2510.32%
Aug 259.74%
Aug 259.77%
Aug 2510.26%
Aug 2513.28%
Aug 2516.16%
Jul 2515.14%
Jul 2515.88%
Jul 2514.32%
Jul 2514.85%
Jun 2516.38%
Jun 2517.16%
Jun 2517.52%
Jun 2516.71%
May 2515.35%
May 2518.25%
May 2517.48%
May 2519.37%
May 2522.8%
Apr 2524.46%
Apr 2525.75%
Apr 2522.65%
Apr 2521.91%
Mar 2519.55%
Mar 2518.3%
Mar 2517.38%
Mar 2517.75%
Feb 2517.82%
Feb 2518.57%
Feb 2518.67%
Feb 2528.98%
Jan 2527.87%
Jan 2526.49%
Jan 2526.04%
Jan 2529.35%
Jan 2524.24%
Dec 2427%
Dec 2427.66%
Dec 2424.37%
Dec 2424.34%
Nov 2425.01%
Nov 2425.28%
Nov 2424.08%
Nov 2427.87%
Nov 2433.97%
Oct 2434.97%
Price to Sales
0.10.20.30.4med 0.23Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NUS Price to Sales by year
PeriodPrice to Sales
Sep 260.17
Sep 260.17
Sep 260.17
Aug 260.17
Aug 260.17
Aug 260.17
Aug 260.18
Jul 260.17
Jul 260.17
Jul 260.18
Jul 260.17
Jul 260.17
Jun 260.18
Jun 260.17
Jun 260.18
Jun 260.18
May 260.19
May 260.2
May 260.2
May 260.24
May 260.24
Apr 260.25
Apr 260.26
Apr 260.25
Apr 260.24
Mar 260.23
Mar 260.23
Mar 260.23
Mar 260.25
Feb 260.28
Feb 260.28
Feb 260.27
Feb 260.34
Jan 260.34
Jan 260.35
Jan 260.37
Jan 260.33
Jan 260.31
Dec 250.31
Dec 250.33
Dec 250.34
Dec 250.32
Nov 250.31
Nov 250.32
Nov 250.3
Nov 250.29
Oct 250.33
Oct 250.34
Oct 250.32
Oct 250.31
Oct 250.35
Sep 250.37
Sep 250.37
Sep 250.37
Sep 250.35
Aug 250.37
Aug 250.37
Aug 250.35
Aug 250.27
Aug 250.24
Jul 250.26
Jul 250.25
Jul 250.27
Jul 250.26
Jun 250.24
Jun 250.23
Jun 250.22
Jun 250.24
May 250.26
May 250.22
May 250.22
May 250.2
May 250.18
Apr 250.17
Apr 250.16
Apr 250.18
Apr 250.18
Mar 250.21
Mar 250.22
Mar 250.23
Mar 250.23
Feb 250.23
Feb 250.22
Feb 250.22
Feb 250.18
Jan 250.18
Jan 250.19
Jan 250.2
Jan 250.17
Jan 250.21
Dec 240.19
Dec 240.18
Dec 240.21
Dec 240.21
Nov 240.2
Nov 240.2
Nov 240.21
Nov 240.18
Nov 240.17
Oct 240.17
EV/EBITDA
051015med 3.27Mar 24Jul 24Jul 25Nov 25Feb 26Jun 26Sep 26
NUS EV/EBITDA by year
PeriodEV/EBITDA
Sep 267.9
Sep 267.88
Sep 267.87
Aug 267.88
Aug 267.74
Aug 267.82
Aug 262.64
Jul 262.53
Jul 262.49
Jul 262.55
Jul 262.54
Jul 262.46
Jun 262.56
Jun 262.46
Jun 262.63
Jun 262.59
May 262.75
May 262.8
May 262.87
May 263.26
May 261.81
Apr 261.87
Apr 261.94
Apr 261.87
Apr 261.85
Mar 261.79
Mar 261.79
Mar 261.8
Mar 261.89
Feb 262.04
Feb 262.09
Feb 262.02
Feb 262.98
Jan 262.93
Jan 263.05
Jan 263.17
Jan 262.86
Jan 262.7
Dec 252.73
Dec 252.85
Dec 252.93
Dec 252.77
Nov 252.75
Nov 252.78
Nov 252.68
Nov 252.55
Oct 252.93
Oct 253
Oct 252.92
Oct 252.82
Oct 253.09
Sep 253.31
Sep 253.27
Sep 253.26
Sep 253.12
Aug 253.29
Aug 253.28
Aug 253.14
Aug 252.48
Aug 2510.67
Jul 2511.26
Jul 2510.82
Jul 2511.8
Jul 2511.45
Jun 2510.56
Jun 2510.16
Jun 259.99
Jun 2510.38
May 2511.14
May 259.67
May 2510.01
May 259.22
Aug 248.99
Jul 248.92
Jul 248.62
Jul 248.76
Jul 249.06
Jun 248.83
Jun 249.79
Jun 249.78
Jun 2410.2
May 2410.26
May 2410.2
May 2410.41
May 2410.19
May 248.92
Apr 248.87
Apr 249.2
Apr 248.75
Apr 248.97
Mar 249.57
Mar 248.87
Mar 249.31
Mar 249.07
Mar 249.02
Feb 249
Feb 249.51
Feb 248.29
Feb 248.48
Jan 248.69
Price/Operating Cashflow
02468med 3.91Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NUS Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 264.66
Sep 264.64
Sep 264.63
Aug 264.64
Aug 264.53
Aug 264.59
Aug 263.48
Jul 263.29
Jul 263.22
Jul 263.32
Jul 263.32
Jul 263.18
Jun 263.35
Jun 263.18
Jun 263.47
Jun 263.41
May 263.67
May 263.76
May 263.88
May 264.54
May 264.35
Apr 264.56
Apr 264.78
Apr 264.55
Apr 264.48
Mar 264.31
Mar 264.31
Mar 264.34
Mar 264.62
Feb 265.13
Feb 265.27
Feb 265.06
Feb 265.97
Jan 265.86
Jan 266.11
Jan 266.37
Jan 265.7
Jan 265.35
Dec 255.43
Dec 255.67
Dec 255.86
Dec 255.51
Nov 255.46
Nov 255.53
Nov 255.31
Nov 255.04
Oct 255.67
Oct 255.83
Oct 255.66
Oct 255.45
Oct 256.02
Sep 256.48
Sep 256.4
Sep 256.37
Sep 256.08
Aug 256.44
Aug 256.42
Aug 256.12
Aug 254.73
Aug 253.75
Jul 254
Jul 253.81
Jul 254.23
Jul 254.08
Jun 253.7
Jun 253.53
Jun 253.46
Jun 253.63
May 253.95
May 253.32
May 253.47
May 253.13
May 252.75
Apr 252.57
Apr 252.44
Apr 252.77
Apr 252.87
Mar 253.21
Mar 253.43
Mar 253.61
Mar 253.54
Feb 253.52
Feb 253.38
Feb 253.36
Feb 252.23
Jan 252.32
Jan 252.44
Jan 252.49
Jan 252.21
Jan 252.67
Dec 242.4
Dec 242.34
Dec 242.66
Dec 242.66
Nov 242.59
Nov 242.56
Nov 242.69
Nov 242.32
Nov 241.97
Oct 241.92
Price to Book
0.20.40.60.8med 0.51Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NUS Price to Book by year
PeriodPrice to Book
Sep 260.44
Sep 260.43
Sep 260.43
Aug 260.43
Aug 260.42
Aug 260.43
Aug 260.33
Jul 260.32
Jul 260.31
Jul 260.32
Jul 260.32
Jul 260.3
Jun 260.32
Jun 260.3
Jun 260.33
Jun 260.33
May 260.35
May 260.36
May 260.37
May 260.43
May 260.43
Apr 260.45
Apr 260.48
Apr 260.45
Apr 260.45
Mar 260.43
Mar 260.43
Mar 260.43
Mar 260.46
Feb 260.51
Feb 260.53
Feb 260.5
Feb 260.67
Jan 260.66
Jan 260.68
Jan 260.71
Jan 260.64
Jan 260.6
Dec 250.61
Dec 250.63
Dec 250.66
Dec 250.62
Nov 250.61
Nov 250.62
Nov 250.59
Nov 250.56
Oct 250.67
Oct 250.69
Oct 250.67
Oct 250.65
Oct 250.71
Sep 250.77
Sep 250.76
Sep 250.76
Sep 250.72
Aug 250.76
Aug 250.76
Aug 250.73
Aug 250.56
Aug 250.54
Jul 250.58
Jul 250.55
Jul 250.61
Jul 250.59
Jun 250.53
Jun 250.51
Jun 250.5
Jun 250.52
May 250.57
May 250.48
May 250.5
May 250.45
May 250.47
Apr 250.44
Apr 250.42
Apr 250.48
Apr 250.49
Mar 250.55
Mar 250.59
Mar 250.62
Mar 250.61
Feb 250.6
Feb 250.58
Feb 250.58
Feb 250.44
Jan 250.46
Jan 250.48
Jan 250.49
Jan 250.44
Jan 250.53
Dec 240.48
Dec 240.46
Dec 240.53
Dec 240.53
Nov 240.51
Nov 240.51
Nov 240.53
Nov 240.46
Nov 240.46
Oct 240.45
Nu Skin Enterprises, Inc.
NUS
Stockpicker

Video analysis: NUS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NUS

Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

businesswire.com · 3 Sep 2026

Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness leader, has been ranked the world's No. 1 company for beauty and wellness device systems by Euromonitor International Ltd. for the third consecutive year.* “Being recognized by Euromonitor is a powerful validation of our long-term vision and commitment to innovation,” said Ryan Napierski, Nu Skin president and CEO. “We believe the future of wellness will be increasingly personalized, intelligent and.

Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

gurufocus.com · 3 Sep 2026

Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness leader, has been ranked the world's No. 1 company for beauty and wellness device systems by E

STMicroelectronics-NUS Lab Strengthens Low-Power Edge AI Push

zacks.com · 25 Aug 2026

STMicroelectronics-NUS Lab Strengthens Low-Power Edge AI Push

STM and NUS launch a four-year lab to advance low-power edge AI for robots, humanoids and drones using local processing and P18 FD-SOI technology.

STMicroelectronics and NUS launch Corporate Lab to power the future of Edge AI in Singapore

globenewswire.com · 24 Aug 2026

STMicroelectronics and NUS launch Corporate Lab to power the future of Edge AI in Singapore

STMicroelectronics and NUS launch Corporate Lab to power the future of Edge AI in Singapore HELIX joint R&D initiative to enable new generative and embodied AI use cases at the edge through system-to-silicon innovation Research will focus on memory-centric architectures, innovative in-memory computing, scalable compute-and-memory systems, and advanced silicon and embedded-memory technologies Corporate Lab will strengthen Singapore's advanced semiconductor research capabilities and support the development of future edge AI talent and innovation Singapore, 24 August 2026 – STMicroelectronics N.V. (“ST”) (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, and the National University of Singapore (NUS) have officially launched the ST–NUS HELIX Corporate Lab, a four-year strategic research initiative focused on advancing the next generation of edge AI technologies.

Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26

newsfilecorp.com · 11 Aug 2026

Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26

Dallas, Texas--(Newsfile Corp. - August 11, 2026) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, adj NI, and adj EPS of $320.1M, $10.0M, and $0.20, respectively.

Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y

zacks.com · 11 Aug 2026

Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y

NUS' second-quarter revenues fall 17.1% and EPS drops 53.5%, while it cuts the 2026 revenue and adjusted EPS outlooks.

Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript

seekingalpha.com · 11 Aug 2026

Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript

Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript

Nu Skin Enterprises Q2 Earnings Call Highlights

marketbeat.com · 11 Aug 2026

Nu Skin Enterprises Q2 Earnings Call Highlights

Nu Skin Enterprises NYSE: NUS reported second-quarter revenue of $320.1 million and adjusted earnings per share of $0.20, as the company continued the rollout of its Prysm iO wellness platform and pursued cost and margin initiatives.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.